1.13
-0.04 (-3.42%)
-0.04 (-3.42%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 47,999 |
|
|||||
| News | (1) | ||||||
| Day High | 1.19 | Low High |
|||||
| Day Low | 1.11 | ||||||
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Tenax Therapeutics Inc | TENX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.04 | -3.42% | 1.13 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.16 | 1.11 | 1.19 | 1.16 | 1.17 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 200 | 47,999 | $ 1.15 | $ 55,062 | - | 1.01 - 3.68 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:45:04 | formt | 167 | $ 1.13 | USD |
Period:
Draw Mode:
Tenax Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 28.48M | 25.21M | 20.85M | $ - | $ - | -1.39 | -0.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 16.30% |
Tenax Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TENX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.30 | 1.35 | 1.11 | 1.22 | 73,729 | -0.17 | -13.08% |
| 1 Month | 1.53 | 1.54 | 1.11 | 1.33 | 82,995 | -0.40 | -26.14% |
| 3 Months | 1.40 | 1.9594 | 1.11 | 1.52 | 133,862 | -0.27 | -19.29% |
| 6 Months | 2.02 | 2.30 | 1.11 | 1.72 | 120,764 | -0.89 | -44.06% |
| 1 Year | 1.12 | 3.68 | 1.01 | 2.07 | 1,685,035 | 0.01 | 0.89% |
| 3 Years | 1.87 | 5.12 | 0.25 | 1.86 | 877,135 | -0.74 | -39.57% |
| 5 Years | 39.00 | 53.00 | 0.25 | 4.88 | 705,820 | -37.87 | -97.1% |
Tenax Therapeutics Description
| Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. The Company has a world-class scientific advisory team including recognized global experts in pulmonary hypertension. The Company owns North American rights to develop and commercialize levosimendan and has recently released topline data regarding their Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF). For more information, visit www.tenaxthera.com. |
